Table 2:
Mortality and Morbidity Events at delivery hospitalization by delivery mode
| Vaginal delivery (n=238) | Intrapartum cesarean delivery (n=171) | Not Labored cesarean delivery (n=318) | Intended vaginal delivery (vaginal delivery + Intrapartum cesarean delivery) (n=409) | Cesarean delivery (Intrapartum + Intended cesarean delivery) (n=489) | Intended: p-value Intended vaginal delivery vs. Intended cesarean delivery | As treated: p-value actual vaginal delivery vs. intrapartum + Intended cesarean delivery | |
|---|---|---|---|---|---|---|---|
| In-hospital Mortality | 0 (0.0%) | <10 | <10 | <10 | <10 | ||
| Non-Transfusion morbidity | 35 (14.7%) | 66 (38.6%) | 78 (24.5%) | 101 (24.7%) | 144 (29.4%) | 0.96 | <0.001 |
| Individual Morbidity Elements | |||||||
| Acute myocardial infarction | 0 (0.0%) | 0 (0.0%) | <10 | 0 (0.0%) | <10 | ||
| Dissection (not aneurysm) | 0 (0.0%) | 0 (0.0%) | <10 | 0 (0.0%) | <10 | ||
| Acute renal failure | <10 | 16 (9.4%) | 18 (5.7%) | 18 (4.4%) | 34 (7.0%) | ||
| Acute respiratory distress syndrome | 10 (4.2%) | 29 (17.0%) | 32 (10.1%) | 39 (9.5%) | 61 (12.5%) | ||
| Amniotic fluid embolism | 0 (0.0%) | <10 | <10 | <10 | <10 | ||
| Cardiac arrest | 0 (0.0%) | <10 | <10 | <10 | <10 | ||
| Ventricular fibrillation | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | ||
| Conversion of cardiac rhythm | <10 | <10 | <10 | <10 | <10 | ||
| Disseminated intravascular coagulation | <10 | <10 | <10 | 12 (2.9%) | 16 (3.3%) | ||
| Heart failure or arrest during surgery or procedure | 0 (0.0%) | <10 | <10 | <10 | <10 | ||
| Puerperal cerebrovascular disorders | <10 | <10 | <10 | <10 | <10 | ||
| Pulmonary edema | <10 | <10 | <10 | 13 (3.2%) | 14 (2.9%) | ||
| Acute heart failure | 11 (4.6%) | <10 | 17 (5.3%) | 20 (4.9%) | 26 (5.3%) | ||
| Severe anesthesia complications | <10 | <10 | <10 | <10 | <10 | ||
| Sepsis | <10 | 12 (7.0%) | <10 | 20 (4.9%) | 19 (3.9%) | ||
| Shock | <10 | 11 (6.4%) | <10 | 16 (3.9%) | 20 (4.1%) | ||
| Sickle cell disease with crisis | 0 (0.0%) | <10 | <10 | <10 | <10 | ||
| Air and thrombotic embolism | <10 | <10 | <10 | 11 (2.7%) | 15 (3.1%) | ||
| Temporary tracheostomy | 0 (0.0%) | 0 (0.0%) | <10 | 0 (0.0%) | <10 | ||
| Ventilation | <10 | 19 (11.1%) | 23 (7.2%) | 23 (5.6%) | 42 (8.6%) | ||
| Hysterectomy | <10 | <10 | <10 | <10 | <10 | ||
| Intensive care stay | 40 (16.8%) | 56 (32.7%) | 117 (36.8%) | 96 (23.5%) | 173 (35.4%) | ||
| Length of stay after delivery | 1 [1, 2] | 3 [2, 5] | 3 [2, 5] | 2 [1, 3] | 3 [2, 5] | ||
| Hospital Readmission (n,%) | |||||||
| 42-day Readmission | <10 | 25 (14.6%) | 25 (7.9%) | 34 (8.3%) | 50 (10.2%) | ||
| 90-day Readmission | 12 (5.0%) | 27 (15.8%) | 30 (9.4%) | 39 (9.5%) | 57 (11.7%) | 0.96 | 0.004 |
| Vasopressor use (any) * | <10 | 18 (10.5%) | 36 (11.3%) | 23 (5.6%) | 54 (11.0%) | ||
| Norepinephrine | <10 | 11 (6.4%) | 17 (5.3%) | 16 (3.9%) | 28 (5.7%) | ||
| Vasopressin | 0 (0.0%) | 15 (8.8%) | 26 (8.2%) | 15 (3.7%) | 41 (8.4%) | ||
| Both | 0 (0.0%) | <10 | <10 | <10 | 15 (3.1%) | ||
| Inotrope use (any) † | <10 | <10 | 23 (7.2%) | 11 (2.7%) | 32 (6.5%) | ||
| Epinephrine | 0 (0.0%) | <10 | <10 | <10 | <10 | ||
| Dobutamine | <10 | <10 | 10 (3.1%) | <10 | 14 (2.9%) | ||
| Dopamine | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | ||
| Milrinone | <10 | <10 | 11 (3.5%) | <10 | 14 (2.9%) | ||
| More than one inotrope | 0 (0.0%) | 0 (0.0%) | <10 | 0 (0.0%) | <10 | ||
| ECMO use | 0 (0.0%) | <10 | <10 | <10 | <10 | ||
| Any pulmonary vasodilator | 48 (20.2%) | 49 (28.7%) | 107 (33.6%) | 97 (23.7%) | 156 (31.9%) | ||
| Calcium Channel Blockers | 41 (17.2%) | 40 (23.4%) | 87 (27.4%) | 81 (19.8%) | 127 (26.0%) | ||
| Prostacyclin Analogues | <10 | <10 | 15 (4.7%) | 11 (2.7%) | 23 (4.7%) | ||
| Phosphodiesterase-5 Inhibitors | <10 | <10 | 18 (5.7%) | 10 (2.4%) | 23 (4.7%) | ||
| Obstetric morbidity | |||||||
| Blood transfusion <4 units red blood cells | 27 (11.3%) | 36 (21.1%) | 50 (15.7%) | 63 (15.4%) | 86 (17.6%) | ||
| Blood transfusion 4 or more units red blood cells | <10 | 19 (11.1%) | 24 (7.5%) | 26 (6.4%) | 43 (8.8%) | 0.53 | 0.003 |
*
Norepinephrine or vasopressin or both
†
Epinephrine, dobutamine, dopamine and, or milrinone
Values <10 are suppressed